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A B S T R A C T
Continuing and expanding our previous work on flavonoid oxidovanadium(IV) (VO) metal complexes as
possible anti-cancer agents, the VOapigenin compound was synthesized and characterized. An
“acetylacetone-like” coordination through the C¼O and O moieties of the ligand to the metal center
with one apigenin ligand per metal ion was assumed using different spectroscopies and elemental
analysis as well as thermal measurements. The vibrational experimental spectrum of VOapigenin was
supported by theoretical calculations. According to the structure of the flavonoid it exerted mild
antioxidant properties that were enhanced by metal coordination. The compounds showed moderate
anticancer activity on lung A549 and cervix HeLa cancer cell lines, displaying an incubation time
dependent behavior. Cellular increase of reactive oxygen species (ROS) and glutathione depletion have
been measured upon incubation with the compounds. These cell killing activities were reverted when
natural antioxidants were incubated with the compounds and the addition of the antioxidant agent N-
acetylcysteine generated depletion of the cellular ROS levels. Therefore, a stress oxidative mechanism of
action has been assumed. Moreover, the compounds showed no toxicity against Artemia salina and were
not mutagenic. Both apigenin and the complex could be transported and stored by bovine serum albumin
with similar binding constants and mechanisms than other VOflavonoid complexes.
© 2017 Elsevier B.V. All rights reserved.
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According to a study of the International Agency of Research for
Cancer, it is expected that the mortality due to cancer may double
in the next 50 years, rising to 10 million by the year 2020 [1].
Cervical cancer represents the second leading cause of death inAbbreviations: AAPH, 2,2-azobis (2- amidinopropane) dihydrochloride; Api-
genin (api), 5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one; BSA, Bovine
serum albumin; DMEM, Dulbecco's Modified Eagle's medium; DPPH., 1,1-diphenyl-
2-picrylhydrazyl; FBS, fetal bovine serum; H2DCFDA, 20 ,70-dichlorodihydrofluor-
escein diacetate; GSH, glutamylcysteinylglycine reduced glutathione; GSSG,
oxidized glutathione; LC50, median lethal concentration; MI, mutagenic index;
MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide; NAC, N-ace-
tyl-L-cysteine; NBT, nitroblue tetrazolium; PBS, phosphate-buffered saline; PMS,
phenazine methosulfate; ROS, reactive oxygen species; VO(api), [VO(apigenin)
(H2O)2]Cl.
* Corresponding authors.
E-mail addresses: naso@quimica.unlp.edu.ar (L.G. Naso),
williams@quimica.unlp.edu.ar (P.A.M. Williams).
http://dx.doi.org/10.1016/j.jphotochem.2017.05.007
1010-6030/© 2017 Elsevier B.V. All rights reserved.women worldwide and, in general, is strongly associated with the
infection of human papiloma viruses (HPVs) [2,3], while lung
cancer is the leading cause of cancer-related mortality worldwide
and non-small cell lung cancer (NSCLC) accounts for higher than
80% of all lung cancers [4]. Researchers are being interested in
natural compounds for enhancing cancer prevention and treat-
ment. Plant-based diet contains substantial quantities of mole-
cules that have chemopreventive potential to reduce the risk from
several forms of human cancers. Flavonoids are phenolic
compounds widely distributed in plants, which display a variety
of biological activities, such as antioxidant, free radical scavengers,
prevention of coronary heart disease and hepatoprotective, anti-
inflammatory, and anticancer activities [5].
Apigenin, 5,7-Dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-
one (Fig. 1), is a flavonoid belonging to the flavones structural class,
present in abundance in fruits and vegetables such as oranges,
grapefruit, celery, parsley, onions, chamomile and wheat sprouts. It
has been reported that apigenin is a potent inhibitor of cell growth
and inducer of apoptosis in various human cancer cells [6] and
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Fig. 1. Schematic representation of apigenin.
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proposed [7,8]. Besides, there exist evidence that apigenin induced
apoptosis by generation of reactive oxygen species (ROS) on
different cancer cell lines [9–13].
The most rational approach to cancer chemoprevention is to
design and test new agents that act on specific molecular and
cellular targets. Since many flavonoids are natural chelators and
flavonoid metal complexes have showed significantly higher
cytotoxic activity than those of the parent flavonoids, we have
been preparing several oxidovanadium(IV) ion (VO) complexes
with flavonoids for over ten years and determined the improve-
ment of their anticancer activities and their mechanisms of action
[14]. The aim of this study is to prepare a new oxidovanadium(IV)
based antitumor compound with apigenin (api) and investigate the
biological behavior and a probable synergistic effect. Human lung
A549 and human cervix cancer HeLa cell lines have been selected
to study the possible anticancer effect of VOapi. The complex
VOapi has been characterized by FTIR, EPR, UV–vis and diffuse
reflectance spectroscopic studies both in solid state and in
solution. DFT computational studies have been performed to
optimize the structure of the complex and to study the vibrational
spectrum. According to the structure of apigenin the flavonoid
behaves as a mild antioxidant agent, but this property has been
improved by coordination to the metal center. However, both
compounds are able to produce reactive oxygen species (ROS) in
both cell lines. The depletion of the tripeptide g-glutamylcystei-
nylglycine, glutathione levels in its reduced form (GSH), associated
with the increase of ROS in cells is an indication that the
mechanism of action of the compounds occurs through oxidative
stress. Toxicological studies demonstrated that the complex and
the parent drugs did not show either toxicity (Artemia salina test)
or mutagenicity (Ames test) and it has also been determined that
the compounds could be stored and transported by bovine serum
albumin (BSA).
2. Experimental
2.1. Materials and methods
Apigenin (Xi’an App-Chem Bio(Tech) Co., Ltd) and oxidovana-
dium(IV) chloride (50% aqueous solution, Carlo Erba) were used as
supplied. Corning or Falcon provided tissue culture materials.
Dulbecco’s modified Eagle’s medium (DMEM) was purchased from
Gibco (Gaithersburg, MD, USA), TrypleTM from Invitrogen
(Argentina SRL) and fetal bovine serum (FBS) from Internegocios,
Argentina. All other chemicals used were of analytical grade.
Elemental analysis for carbon and hydrogen was performed using a
Carlo Erba EA1108 analyzer. Vanadium content was determined by
the tungstophosphovanadic method [15]. Chloride contents were
measured using an ion-selective electrode (Cole-Parmer 27.502-
12). A Shimadzu system (model TG-50), working in an oxygen flow
of 50 mL min1 and at a heating rate of 10 C.min1 has been used
for the thermogravimetric analysis. Sample quantities ranged
between 10 and 20 mg. UV–vis and diffuse reflectance spectra
(MgO as a standard) were recorded with a Shimadzu 2600/2700spectrophotometer. Infrared spectra were measured with a Bruker
IFS 66 FTIR spectrophotometer from 4000 to 400 cm1 using the
KBr pellet technique. X-band CW-EPR spectra of powdered
samples were obtained at room temperature on a Bruker EMX-
Plus spectrometer, equipped with a rectangular cavity with
100 kHz field modulation. X band EPR spectra of frozen DMSO
solutions were recorded at 120 K, after addition of 5% DMSO to
ensure good glass formation. EPR spectra were simulated with the
EasySpin toolbox based on MATLAB [16]. Fluorescence spectra
were obtained using a Shimadzu (RF6000) luminescence spec-
trometer equipped with a pulsed xenon lamp. The molar
conductance of the complex was measured on a Conductivity
TDS Probe  850084, Sper Scientific Direct, using 103M DMSO
solutions.
2.2. Synthesis of [VO(apigenin)(H2O)2]Cl, VOapi
Apigenin (0.5 mmol) was dissolved in absolute ethanol under
heating and stirring. After cooling, VOCl2 (50% aqueous solution,
0.25 mmol) was added to the ligand solution under stirring, under
nitrogen atmosphere. The pH of the solution was adjusted to 5 by
addition of 1 M NaOH solution and the solvent was removed up to
2 mL under vacuum. The suspension was filtered and the green
powder, characterized as [VO(apigenin)(H2O)2]Cl (VOapi), was
washed three times with absolute ethanol and dried in an oven at
60 C. Anal. calcd. For C15H13O8VCl: C 44.1, H 3.2, V 12.5, Cl 8.7.
Found: C 44.2, H 3.2, V 12.4, Cl 8.8%. Thermogravimetric analysis
(oxygen atmosphere, 50 mL/min): The water loss finishes at
relatively high temperatures, (187 C) and the total release of
water involves two water molecules (Dwcalc = 8.3%, Dvexp = 8.4%).
According to the temperature of dehydration it has been assumed
that the two water molecules belong to the coordination sphere of
the oxidovanadium(IV) cation. After dehydration, the compound
degraded in a series of two consecutive TG steps observed up to
600 C. Weight constancy is attained 700 C and the weight of the
remaining solid residue, collected at 700 C was of 22.4%, in good
agreement with the expected value of 22.3%. The presence of V2O5
in the residue was confirmed by FTIR spectroscopy. Diffuse
reflectance: 268, sh nm, 360 nm, 395 nm, 453 nm, >800 nm. The
molar conductance of the complex measured in DMSO, Lm= 29
(V1.cm2.mol1), suggested a 1:1 electrolyte [17].
2.3. Computational methodology for assignment of vibrational modes
As suitable single crystals for structural determinations could
not be obtained, the geometrical parameters and the vibrational
determinations and assignments of VO(api) were studied by
computational methodologies. Theoretical calculations were
performed using tools from density functional theory (DFT) [18–
20] as implemented in the GAUSSIAN 09 program package [21].
The structural and electronic properties of the ligand apigenin
were further studied by using DFT calculations [22–24] and the
optimization procedures were carried out using the Beck three-
parameters hybrid exchange-correlation functional, known as
B3LYP [25] and employing the 6–311G basis set [26] reached by
adding polarization and diffuse functions for all atoms. This further
optimized geometry was employed to build the oxidovanadium
(IV) complex VOapi. The complex was first optimized at the same
level of theory that the ligand and then reoptimized employing
different functionals and basis set [27].
Molecular structure of the ligand and the complex VOapi were
optimized in gas phase. Vibrational calculations at the same level
of theory were performed to determine the consistency of the
minimum in the potential energy surface and to assign the
theoretical vibrational spectra. The IR frequencies were analyzed
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Vibrational Energy Distribution Analysis (VEDA 4) program [28].
2.4. Spectrophotometric titrations and stability studies
To establish the stoichiometry of the complex in solution the
molar ratio method was applied. A solution of apigenin (EtOH,
4 105M) was prepared and its electronic spectrum recorded.
The absorption spectra of different ethanolic solutions of
4 105M apigenin and VOCl2 in ligand-to-metal molar ratios
from 10 to 0.5 (pH 5.0, NaOH and N2 atmosphere) were measured.
Plots of the absorbance at 298 nm vs the ligand-to-metal ratios
allowed the stoichiometric determination. Stability studies have
been performed measuring the variation of the VOapi electronic
absorption spectra (DMSO, N2) vs. time.
2.5. Antioxidant properties
The superoxide dismutase (SOD) activity was examined
indirectly using the nitroblue tetrazolium (NBT) assay. The indirect
determination of the activity of apigenin and the VOapi was
assayed by their ability to inhibit the reduction of NBT by the
superoxide anion generated by the phenazine methosulfate (PMS)
and reduced nicotinamide adenine dinucleotide (NADH) system.
As this reaction proceeded, the formazan color developed and a
change from yellow to blue was observed which was associated
with an increase of the intensity of the band at 560 nm in the
absorption spectrum. The system contained 0.5 mL of sample,
0.5 mL of 1.40 mM NADH and 0.5 mL of 300 mM NBT, in 0.1 M
KH2PO4-NaOH buffer (pH 7.5). After incubation at 25 C for 15 min,
the reaction was started by adding 0.5 mL of 120 mM PMS. Then,
the reaction mixture was incubated for 5 min. Each experiment
was performed in triplicate and at least three independent
experiments were performed in each case. The amount of
compound that gave a 50% inhibition (IC50) was obtained by
plotting the percentage of inhibition versus the negative log of the
concentration of the tested solution.
The capacity of apigenin and the VOapi to scavenge hydroxyl
radicals (generated by the ascorbate-iron-H2O2 system) has been
measured. Briefly, the reaction mixture contained 3.75 mM 2-
deoxyribose, 2.0 mM H2O2, 100 mM FeCl3, and 100 mM EDTA
without or with the tested compounds in 20 mM KH2PO4-KOH
buffer, pH 7.4. The reaction was triggered by the addition of 100 mM
ascorbate and the mixture was incubated at 37 C for 30 min.
Solutions of FeCl3, ascorbate, and H2O2 were made up in deaerated
water immediately before use. The extent of deoxyribose
degradation by hydroxyl radical was measured with the thio-
barbituric acid method [29].
The inhibition of peroxyl radical was measured by generation of
the radicals by the thermal decomposition of 2,2-azobis (2-
amidinopropane) dihydrochloride (AAPH) [30]. AAPH was chosen
due to its ability to generate free radicals at a steady rate for
extended periods of time (half-life of 175 h). The consumption of
pyranine was followed spectrophotometrically by the decrease in
absorbance at 454 nm with a thermostated cell at 37 C. The
reaction solutions contained AAPH (50 mM), pyranine (50 mM) and
several concentrations of the tested compounds. The delay of
pyranine consumption (lag phase) was calculated as the time
before the consumption of pyranine started (notable reductions in
absorbance) [31].
The antiradical activity of apigenin and VOapi was also
measured in terms of the capacity of the compounds to scavenge
DPPH (1,1-diphenyl-2-picrylhydrazyl) radicals. The measure-
ments were performed in triplicate using a modified method of
Yamaguchi et al. [32]. A methanolic solution of (DPPH) (4 mL,
40 ppm) was added to 1 mL of the antioxidant solutions in 0.1 Mtris(hydroxymethyl)aminomethane-HCl buffer (pH 7.1) at 25 C,
giving a final concentration of 10 mM. After 60 min in the dark, the
absorbance at 517 nm was measured and compared with the
absorbance of the control prepared in a similar way without the
addition of the antioxidants (this value was assigned arbitrarily as
100%).
2.6. Biological assays
2.6.1. Cell culture
Human lung cancer cell line A549 and human cervical cancer
cell line HeLa were maintained at 37 C in a 5% carbon dioxide
atmosphere using DMEM supplemented with 100 U/mL penicillin,
100 mg/mL streptomycin and 10% (v/v) fetal bovine serum as the
culture medium. When 70–80% confluence was reached, cells were
subcultured using TrypLETM from Gibco (Gaithersburg, MD, USA)
and free phosphate buffered saline (PBS) (11 mM KH2PO4, 26 mM
Na2HPO4, 115 mM NaCl, pH 7.4). For the experiments, cells were
grown in multi-well plates. When cells reached 70% confluence,
the monolayers were washed twice with DMEM and then
incubated with the different compounds.
2.6.2. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazolium
bromide) assay
A549 and HeLa cells were seeded at a density of 1 105 per well
in 48 well plates, grown overnight and treated with either vehicle,
apigenin, VOapi or oxidovanadium(IV) cation at different concen-
trations in FBS free medium. Dimethyl sulfoxide (DMSO) has been
used as the dissolution vehicle to yield a maximum final
concentration of 0.5% in the treated well (Sigma-Aldrich, St. Louis,
MO). After 24, 48 or 72 h of incubation at 37 C, 100 mg per well
MTT (Sigma-Aldrich, St. Louis, MO) was added and incubated for
2 h. The formazan products generated by cellular reduction of MTT
were dissolved in isopropyl alcohol/HCl and the optical density
was measured at 560 nm. All experiments were performed in
triplicate. Data were presented as percentage of cell viability (%) of
the treated group with respect to the untreated cells (control) in
which the viability is assumed to be 100%. To evaluate the cell
viability in the presence of natural antioxidants, the cells were
incubated with different concentrations of the apigenin and VOapi
plus a mixture of vitamins C and E (50 mM each) during 24 h. Then,
the MTT assay was performed [14].
2.6.3. ROS measurements
Intracellular reactive oxygen species (ROS) generation in A549
and HeLa cell lines was measured by oxidation of 20,70-
dichlorodihydrofluorescein diacetate (H2DCFDA) to 20,70-dichloro-
fluorescein (DCF). Briefly, 24-well plates were seeded with 5 104
cells per well and allowed to adhere overnight. Then, different
concentrations of apigenin, VOapi and oxidovanadium(IV) cation
were added for 24 h. Following the compounds treatment, media
was removed and cells were loaded with 10 mM H2DCFDA diluted
in clear media for 30 min at 37 C. Media was then separated and
the cell monolayers rinsed with PBS and lysated into 1 mL 0.1%
Triton-X100. The cell extracts were then analyzed for the oxidized
product DCF by fluorescence spectroscopy (excitation wavelength,
485 nm; emission wavelength, 535 nm) [33]. Using the same assay
as described above, ROS generation in cells was measured in the
presence of NAC (N-acetylcysteine). Cells were pretreated with
5 mM of NAC for 30 min, followed by treatment with apigenin and
VOapi at different concentrations for additional 24 h.
2.6.4. Fluorometric determination of cellular GSH and GSSG levels
Glutathione (GSH) and Oxidized glutathione (GSSG) levels were
determined in A549 and HeLa cell lines in culture. Confluent cell
monolayers from 24 well dishes were incubated with different
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at 37 C for 24 h. Then, the monolayers were washed with PBS and
harvested by incubating them with 300 mL Triton 0.1% for 30 min.
For GSH determinations,100 mL aliquots were mixed with 1.8 mL of
ice cold phosphate buffer (Na2HPO4 0.1 M-EDTA 0.005 M, pH 8) and
100 mL o-phthaldialdehyde (OPT) (0.1% in methanol) as it was
described by Hissin and Hilf [34]. For the determination of GSSG,
100 mL aliquots were mixed with 1.8 mL NaOH 0.1 M and OPT but
previously and to avoid GSH oxidation, the cellular extracts for
GSSG determination were incubated with 0.04 M of N-ethyl-
maleimide (NEM). The fluorescence at an emission wavelength of
420 nm was determined after excitation at 350 nm. Standard
curves with different concentrations of GSH were processed in
parallel. The protein content in each cellular extract was quantified
using the Bradford assay [35]. The ratio GSH/GSSG, which is a
better marker for the cellular redox status, was calculated as%
control for all the experimental conditions.
2.6.5. Cell morphology
To evaluate the morphology of the cells, they were grown in six
well per plates and incubated overnight with fresh serum-free
DMEM plus 0 (basal), 10 and 100 mM solutions of the complex. The
monolayers were subsequently washed twice with PBS, fixed with
methanol and stained with 1:10 dilution of Giemsa for 10 min.
Next, they were washed with water and the morphological
changes were examined by light microscopy.
2.7. Toxicological assays
2.7.1. Artemia salina test
For the determination of the acute toxicity of the metal, the
ligand apigenin, VOCl2 and the VOapi complex in brine shrimp,
eggs of A. salina were incubated in a hatching chamber with
artificial seawater at 20–30 C (One liter of seawater contains:
NaCl, 23 g; MgCl26H2O, 11 g; Na2SO4, 4 g; CaCl22H2O, 1.3 g; KCl,
0.7 g). The pH was adjusted to 9.0 using Na2CO3 to avoid risk of
death to the Artemia larvae by the decrease of pH during
incubation. [36] After 24 h, the larvae (nauplii) were extracted
and counted using a micropipette. For the oxidovanadium(IV)
cation, the ligand apigenin and the VOapi complex, six concen-
trations (in triplicate) were tested in order to determine the dose-
response relationship and negative (distilled water) and a positive
(K2Cr2O7) controls were used. Concentrations tested were 300,150,
75, 37.5, 18.8, and 9.4 mg.mL1. The selected concentrations were in
the order of those used for the anticancer determinations. TheTable 1
Tentative assignments of the FTIR spectra of apigenin, its sodium salt Na-apigenin and
apigenin Na-apigenin VOapi 
3322 sh, 3279 m 3417 m 3380 m 
3092 m 3058m 3087m 
2922 m, 2831 m 2974 m, 2925 m, 2855 m 2954 m, 2893
2762 m, 2695 m, 2616 s 2766 m, 2693
1657 vs 1660 vs 1638 vs 
1612 vs 1602 vs 1596 vs 
1584 s 1582 sh – 
1556 s 1556 vs 1529 vs 
1498 vs 1499 m 1492 vs 
1447 s 1439 m 1452 m 
1355 vs 1372 s, 1340 sh 1353 s 
1243 vs 1241 s 1246 s 
1223 s – – 
1178 vs, 1159 sh 1169 vs 1171 vs 
1114 m 1121 m 1104 m 
1029 m 1023 w 1040 m 
– – 977 m 
s, strong; vs, very strong; w, weak; m, medium; sh, shoulder. n: stretching vibration; dwells containing the sample and 10 larvae of brine shrimp,
including the control groups, were filled to a total volume of 100 mL
with artificial seawater. After 24 h, live larvae were counted and the
median lethal concentration (LC50) values were estimated.
2.7.2. Ames test
The mutagenic potential of novel drugs needs to be investigated
because some chemical agents which show mutagenicity can
induce cancer. Mutagenicity of the compounds was evaluated by
the Salmonella/microsome assay that is based on the plate-
incorporation method proposed by Maron and Ames [37], using
Salmonella typhimurium TA98 and Salmonella typhimurium TA100.
The test strains were obtained from frozen culture and were grown
overnight for 12–14 h at 37 C in Mueller Hinton broth. The
different concentrations of the metal, the ligand apigenin and the
VOapi complex (300,150, 75, 37.5 and 18.8 mg/plate) were added to
2 mL of top agar mixed with 100 mL of bacterial culture (1–2  108
cells mL1) adding this mixture to a plate with minimal agar. These
plates were incubated at 37 C for 48 h and the number of His+
revertant colonies was counted. All experiments were made in
duplicate. The Mutagenic index (MI) was calculated as the average
number of revertants per plate divided by the average number of
revertants per plate from the negative control for each dose.
2.8. Bovine serum albumin (BSA) interaction
BSA was dissolved in Tris-HCl (0.1 M, pH 7.4) buffer to attain a
final concentration of 6 mM. Solutions of apigenin and VOapi were
added dropwise to the BSA solution and left to rest to ensure the
formation of homogeneous solutions with concentrations ranging
from 2 to 100 mM with an incubation time of 1 h. The fluorescence
intensity was measured (excitation at 280 nm) at 298, 303 and
310 K. For each sample and concentration, three independent
replicates were performed. Both excitation and emission slits were
set at 10 nm throughout this study.
3. Results and discussion
3.1. Solid characterization of the complex
3.1.1. Vibrational spectroscopy
The vibrational FTIR spectral data of the solids apigenin, its
sodium salt (Na-apigenin) and VOapi in KBr pellets is displayed in
Table 1. The major changes in the infrared spectrum upon
coordination are: VOapi (band postitions in cm1).
Assignments
n(OH) H-bond
n(CH)
 m, 2822 m n(CH)
 m, 2630 m H-bond
n(C¼O)
n(C¼O) + n(C2 = C3), ring A quinoid stretching vibration
d(OH) + ring stretching vibration
n(C¼C), Ring C
d(CH)inplane, n(C¼C)
d(CH)inplane, n(C¼C)
n(COH) + n(CC)
n(CO-C), n(COH)
n(CH)inplane, d(OH)
d (COH)inplane
n(COH), d (CH aromatic ring)
d(CH)inplane
n(V = O)
: bending vibration.
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in Na-apigenin) is shifted to lower energies (1638 cm1 in the
complex) owing to the increase in length of the C¼O bond
coordinated to the oxidovanadium(IV) cation.
 The deprotonation and coordination to O(5) is indicated by the
presence of the strong band at 1584 cm1 in apigenin that
disappears upon deprotonation and or complexation.
 The modifications of ring A were detected by the displacements
of the bands 1612 cm1 in apigenin and 1602 cm1 in Na-
apigenin at 1596 cm1 in the complex. The modifications of ring
C were detected by the displacements of the bands 1556 cm1 in
apigenin and Na-apigenin at 1529 cm1 in the complex.
 The shift of the band assigned to d(CH)inplane from 1029 cm1 in
apigenin and 1023 cm1 in Na-apigenin to 1040 cm1 in the
complex indicate the alteration of the ring structure.
 The band at 1243 cm1 associated with n(COC) changed
slightly upon complexation, indicating that the ring oxygen of
the ligand did not form metal-oxygen bonds with the metal ion.
 The band corresponding to the vibrations of ring B at 1498 cm1
was not affected by the interaction of apigenin with the metal
center.
 The position of the V = O stretching band at 977 cm1 is typical
for a coordination sphere of (CO, O) or “acetylacetone-like”
with flavonoids. This conclusion is supported by the measure-
ments of the EPR spectra (see below).
These results suggest that the coordination of the oxidovana-
dium(IV) ion with the apigenin ligand most probably took place via
carbonyl oxygen and 5-OH group after deprotonation to form the
metal-oxygen bonds in the complex.
3.1.2. EPR measurements
Fig. 2 shows the powder EPR spectrum obtained at room
temperature. A very similar spectrum was obtained at low
temperature (not shown). The EPR spectrum of VOapi microcrys-
talline powder gave a unique EPR line, which does not show the
typical eight lines hyperfine splitting pattern of 51V nucleus (I = 7/
2). This fact indicates the presence of magnetic interactions
between paramagnetic oxidovanadium(IV) ions in the solid
complex, which collapse the hyperfine interaction. A similar
behavior has been found for VOnaringenin and VOquercetin
complexes [38,39].300 330 360 390
g1 = 1.9649
lwpp = 9.23 mT
).
u.a(la
n
gi
S
R
P
E
Magn ec  Fiel d (mT)
 exp
 sim
VOapi po wder sample
Fig. 2. Powder EPR spectrum of VOapi obtained at 293 K (solid) together with
simulation (dash dot). Microwave frequency 9.4565 GHz g-factor and linewidth
peak-to-peak (lwpp) obtained by simulation are indicated.3.1.3. DFT calculations
The optimized structures of the ligand and the complex Vapi are
depicted in Figs. 3 and 4, respectively. Computational studies
apigenin at the B3LYP level of theory with different basis sets were
previously reported in the literature [22,23,40]. .Then, the ligand
apigenin was optimized at the level of theory B3LYP/6-311++G**
without any constrains. For the complex VOapi, the optimization
was carried out employing different functionals (B3LYP, B3P86,
M06L, PBE1PBE, MPW1PW91 and B97D) and basis sets (6–31G**
and 6–311++G**). While the triple zeta valence basis set 6–311+
+G**, developed by Pople and coworkers [26], results the best
choice, our results indicate that calculation employing the
functional B97D appears to be the most advantageous one, taking
into account the better correlation with the experimental FTIR
spectrum. Minenkov et al. [40] have investigated the performance
of 8 popular density functionals in reproducing 18 molecular
structures derived from single-crystal X-ray diffraction experi-
ments on ruthenium-based olefin metathesis catalyst precursors.
These authors find that all the methods accounting for dispersion
(B97D, wB97XD, M06, and M06L) give rise to more compact
structures, removing the systematic overestimation of internucle-
ar distances, and suggest a ranking of this functionals (B97D < M06
 wB97XD < M06L). However, they conclude that taking into
account the well-known oscillation problems of the Minnesota
functionals, B97D is a tempting and computationally less
demanding choice. The experimental data (conductimetric,
thermogravimetric and elemental analysis) allowed the confirma-
tion that only one ligand coordinated to the metal center. From the
spectroscopic determinations the coordination mode of the ligand
to the metal center is suggested to occur through C¼O and O
moieties with “acetylacetone-like” coordination, similar to the
coordination oxidovanadium(IV) complexes of chrysin and morin
as predicted by Sanna et al. for acidic pH values [41]. The
coordination sphere is completed by two water molecules
(determined by thermogravimetric measurements). The optimized
structure of VOapi indicates that this complex is a penta-
coordinated complex with distorted square pyramidal geometry.
Representative bond lengths and angles around the vanadium
atom are depicted in Table 2. Taking into account the coordination
sphere around the vanadium center, it can be seen that the
calculated V¼O bond length (1.576 Å) resulted with an intermedi-
ate value between those of bisacetylacetonate oxidovanadium(IV)
(1.56 Å) [42] and the hydrated [VO(H2O)5]2+ ion (1.582 Å) [43].
Besides, the C¼O bond in apigenin of 1.253 Å resulted enlarged
upon coordination 1.309 Å, as expected.
The experimental and the theoretical FTIR spectra of the
complex VOapi, calculated at the same level of theory employed in
the optimization procedure (B97D/6–311 + +G**), are shown inFig. 3. Optimized geometry of apigenin at the level of theory B3LYP/6–311 + +G**.
The gray ball represents C atom, the black ball represents O atom and the white ball
represents H atom.
Fig. 4. Optimized geometry of the complex VOapi at the level of theory B97D/6–311 + +G**. The gray ball represents C atom, the black ball represents O atom, the white ball
represents H atom and the light gray ball represents V atom.
Table 2
Selected bond lengths (Å) and angles () around Vanadium in the VOapi complex
calculated at B97D/6–311 + +G** level of theory.
Bond Lenghtsa VOapi Bond Anglesa VOapi
V(1)-O(2) 1.576 O(2)-V(1)-O(w1) 99.09
V(1)-O(w1) 2.180 O(2)-V(1)-O(w2) 111.99
V(1)-O(w2) 2.119 O(2)-V(1)-O(4) 107.40
V(1)-O(4) 1.947 O(2)-V(1)-O(5) 112.76
V(1)-O(5) 1.893
C(5)-O(5) 1.338
C(4)-O(4) 1.309
a For the denomination of the atoms see Fig. 4.
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agreement, even without the use of scaling factors. However, an
exhaustive vibrational study indicates that the calculated FTIR
spectrum is slightly different from the experimental one. For
example, the band at 977 cm1 in the experimental spectrum was
assigned to the V = O stretching, whereas in the simulation this
vibrational mode appears at 1045 cm1. This difference could be
explained by the fact that the IR spectrum was measured in the
solid state in which the structure is subjected to intra and
intermolecular interactions such us hydrogen bonding and van der
Waals interactions, whereas the calculations for the isolated
molecule have been performed in gas phase. In this context, thember (cm-1)
500100015002000
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al FTIR spectrum (dashed) of the VOapi complex.
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tool for a serious analysis of the vibrational spectra. The analysis of
vibrational results was carried out employing VEDA 4 program in
order to identify the most important components in each
vibrational mode with a description using internal coordinates.
The results of PED analysis are displayed in Table S1 and the
contribution percentages of each coupled mode for the same
wavenumber are indicated in parentheses. For comparative
purposes, Table S1 includes previously reported data of the
vibrational spectrum of apigenin calculated at B3LYP/6-31G(d,p)
level of theory (scaled by 0.9608) [24].
3.2. Solution studies
3.2.1. Electronic spectra
The UV–vis spectrum of the ligand and complex were recorded
in DMSO/EtOH (1/100).
Two acid–base dissociation steps were reported for apigenin:
pKa1 = 6.61 0.07 and pKa2 = 9.31 0.07 [44]. Apigenin at pH
values up to 8 exhibits two major absorption bands in the UV–
vis region, at 340 nm (band I) representing B-ring absorption
(cinnamoyl system), and the absorption in 269 nm (band II)
associated with the A ring portion (benzoyl system).They are
related to the p!p*and n ! p* transitions. At pH values higher
than 9, the absorption spectra is shifted to the long-wavelength
region, 345 nm to 390 nm (pH 9 to 11) (band I) as shown in Fig. S1. It
is observed that deprotonation causes a rather large shift probably
because of the extension of the conjugated system established by
the deprotonated ArO groups.
The UV–vis spectra of a 1:1 mixture of apigenin:oxidovanadium
(IV) cation (Fig. S2) showed a similar spectral pattern than the
ligand in the 250–500 nm region. By comparing both spectral
variations it can be shown that both deprotonation and/or
chelation induced those spectral changes which are qualitatively
parallel in the UV–vis spectral region. Working with 100-fold
concentrated solutions the oxidovanadium(IV) d–d transitions can
be observed (Fig. S3). At pH values of 2 to 3 the typical spectra of VO
(IV) cation in DMSO ([VO(DMSO)5]2+) is displayed. Spectral
changes at higher pH values (from 650 nm to 570 nm) are
indicative of the coordination of the metal with the flavonoid
from pH values higher than 4. Then, a pH value of 5 has been
selected for the synthesis of the complex. The spectrophotometric
titration has been performed following the spectral variation of an
ethanolic 4 105M solution of apigenin at pH 5 with theFig. 6. UV–vis spectra of apigenin (4 105M) with the addition of VOCl2 in ligand-
to-metal ratios from 10.0 to 0.5 (pH 5), nitrogen atmosphere. Inset: spectrophoto-
metric determination of VOapi complex stoichiometry at 298 nm.successive addition of VOCl2 at different ratios, at 298 nm. A
ligand-to-metal ratio 1-1 has been obtained in agreement with the
stoichiometry determined for the solid complex (see Fig. 6).
The complex remained stable in a DMSO solution (no
appreciable changes were observed in the UV–vis spectra) at least
during 1 h (data not shown). Then it can be stated that the complex
did not decompose during the manipulation of the solution for the
biological studies.
3.2.2. EPR spectrum in solution
Fig. 7 shows the EPR spectrum obtained in a DMSO frozen
solution at 120 K. The EPR signal shows the typical eight-line
pattern spectrum for the oxidovanadium(IV) cation systems. The
solution experimental spectrum can be well simulated assuming
g-and A-matrices with rhombic symmetry. This signal indicated
the formation of single mononuclear species after the dissolution
process. The spectral simulation predicted the formation of an
oxidovanadium(IV) chromophore with spin Hamiltonian param-
eters gz = 1.9439, gx = 1.9767 and gy = 1.9717 and hyperfine coupling
constants of Az = 166.8  104 cm1, Ax = 52.3  104 cm1, and
Ay = 61.2  104 cm1.
Using the additivity rule [45] a calculated value of Az = 169.9
 104 cm1 (C¼O 44.7  104 cm1, ArO 38.6  104 cm1,
ODMSO = 43.3 cm1 [46]) has been obtained assuming that the
two coordination water molecules have been replaced by two
solvent molecules in the equatorial plane (DMSO). This value is in
good agreement with the experimental Az value.
3.2.3. Antioxidant determinations
The antioxidant properties have been evaluated by means on
the capacity of the compounds to scavenge reactive oxygen species
(ROS) in vitro. In addition, the capacity of the reduction of the
concentration of the DPPH radical has been evaluated for
comparative purposes (Table 3).
Apigenin did not display SOD activity, as has previously been
reported [47] and the coordination to oxidovanadium(IV) cation
did not improve this activity. The flavonoid showed no activity on
the peroxyl radical scavenging (no phase lag of pyranine
consumption detected at 200 mM) while VOapi showed low
activity (phase lag of pyranine consumption of 1.62 min, at
100 mM). Apigenin and VOapi at a 100 mM concentration displayedFig. 7. Frozen solution EPR spectrum of VOapi (solid) together with simulation
(dashed). Temperature, microwave frequency, and EPR parameters obtained by
simulation are indicated.
Table 3
Antioxidant activities of apigenin, VOapi and the oxidovanadium(IV) cation. a from ref [51].
Compounds O2
 (IC50, mM) DPPH (IC50, mM) OH (IC50, mM) ROO (lag phase, min)
apigenin >100 >100 10 <1, 100 mM
luteolina >100 68 100 3.19, 10 mM
VOapi >100 >100 52 1.62, 100 mM
VOluta >100 >100 17 2.15, 10 mM
V(IV)O2+ 15 >100 >100 <1, 100 mM
1.2, 10 mM
Native SOD 0.21
Table 4
IC50 values for apigenin and VOapi at 24, 48 and 72 h on A549 and HeLa cell lines.
IC50(mM), 24 h IC50(mM), 48 h IC50(mM), 72 h
A549 HeLa A549 HeLa A549 HeLa
Apigenin >100 85.4  1.7 24.8  2.9 20.3  3.2 9.1  1.8 7.6  2.1
VOapi >100 88.1  1.4 17.7  3.1 15.5  1.6 2.2  0.9 9.7  1.9
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of the radicals, respectively. A similar effect for apigenin has
previously been shown [48]. Besides, a weak radical scavenging
potential against DPPH radicals has been reported for apigenin
[49,50]. Table 3 shows that apigenin and VOapi at a 100 mM
concentration were able to scavenge 3% and 16% of the DPPH
radicals, respectively.
The low antioxidant activity of apigenin is related to its
chemical structure. The presence of only one hydroxyl group in
ring B and the lack of the OH group in 3- position directly impact on
its low radical scavenging behavior. Moreover, the absence of 30-
hydroxyl group is especially essential for the antioxidant potency
of flavonoids, because the o-dihydroxy arrangement in ring B have
better electron-donating properties to form ketones after scav-
enging radicals. In this context, it can be seen that apigenin is
structurally related to luteolin with the same substituents in A and
C rings, but differs in the hydroxyl (OH) substitutions in ring C.
Luteolin possesses 30- and 40- cis diol groups in ring B. According to
the relation of the flavonoid structure with its activity, a higher
antioxidant activity has been measured for DPPH and ROO
radicals for luteolin. However, the oxidovanadium(IV) complex of
apigenin improved DPPH and peroxyl scavenging activities but
the complex with luteolin did not exhibit higher scavenger power
[51]. This behavior could be explained by the mode of coordination
of the ligands. In VOluteolin metal coordination involves 30-OH and
40-OH groups of ring B, precluding the involvement of these groups
in the antioxidant action of the complex. On the contrary, the
apigenin coordination involves (C¼O and O) groups of rings A and
C in the chelation to the oxidovanadium(IV) cation that might
enhance electron delocalization of the odd electron of ring C by pConcentrati on,  M
0 20 40 60 80 10 0 12 0
lortn oc
%
0
20
40
60
80
100
120
* *
**
*
    (A)
µ
Fig. 8. Inhibitory effects of apigenin (circles), VOapi (triangles) and oxidovanadium(IV) ca
various concentrations of the compounds for 24 h. The results are expressed as the perce
(SEM) from three separate experiments. * significant values in comparison with the coconjugation when it acts as a radical scavenger, generating a more
stable radical.
3.3. Biological assays
3.3.1. Cell viability
It has previously been shown that apigenin slightly affected the
viability of A549 cells at 24 h incubation [12,52,53] and that the
oxidovanadium(IV) cation induced no cytotoxicity to A549 human
lung cancer cells at the tested concentrations (16% inhibition at
100 mM) [38]. From Fig. 8A it can be seen that the viability of A549
cells at 24 h was also slightly affected when the cells were treated
with VOapi with IC50 values >100 mM.
On the other hand, the effect of the compounds on the HeLa cell
line viability at 24 h incubation was more pronounced. Oxidova-
nadium(IV) cation inhibited 40% of cell viability at 100 mM
(IC50 > 100 mM), as it was previously reported [54] and apigenin
induced cytotoxicity on HeLa cells with approximately 60%
reduction of cell viability at concentration of 100 mM (IC50 = 85.4
mM), in agreement with previous results [53,55,56]. The complex
VOapi showed lower cytotoxicity than the ligand at low concen-Concentrati on,  M
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similar to that of the ligand (Fig. 8B). Apigenin and VOapi
concentrations ranging from 2.5 to 100 mM; at 48 and 72 h
incubation showed a time-dependent cell viability decrease (see
Table 4) on both cell lines. The effects of the free ligand and its
complex with oxidovanadium(IV) cation at all the measured
incubation times were similar on the HeLa cell line and only a low
improvement of the anticancer effect of the flavonoid upon
coordination has been shown for the lung cancer cell line at 72 h
incubation.
It is worth mentioning that there are some discrepancies in the
literature data for the cell viability of A549 and HeLa cell lines at 48
and 72 h with the reported results being quite different from each
othe [9,27,53–59].
3.3.2. Mechanisms of action
Normal cells contain fewer amounts of both ROS and
antioxidants in relation to cancer cells and ROS homeostasis
suffer small changes upon loss of either ROS or antioxidants,
maintaining cells viable and functional. On the contrary, cancer
cells have higher levels of ROS and antioxidants, and then the
increase of ROS generation and/or the inhibition of antioxidant
produced oxidative cancer cell death, while the opposite effect,
prevention of ROS generation or treatment with antioxidants will
produce cytostasis and possibly senescence [60,61]. Therefore, the
persistent pro-oxidative state characterizing cancer cells, as well as
their multiple adaptation mechanisms to minimize the effects of
oxidative damage can be used to develop new therapeutic
strategies. To try to elucidate the mechanism by which apigenin,
VOapi and oxidovanadium(IV) cation exert their cytotoxic effects,
we examined the intracellular levels of ROS in compound-treated
A549 and HeLa cells using the probe DCFH-DA. This probe is cell-
permeable and is cleaved by non-specific esterases and is oxidized
by the ROS produced in the cells to form DCF. Then, the intensity of
DCF fluorescence is proportional to the amount of ROS production.
It can be observed in Fig. 9 that apigenin and VOapi produced the
same effects in both cell lines. In A549 cell line, both compounds
produced a slight increment of ROS levels at concentrations higher
than 80 mM. The oxidovanadium(IV) cation did not increase the
cellular ROS levels [14].Concentration,  M
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Fig. 9. Effect of apigenin (circles), VOapi (triangles) and oxidovanadium(IV) cation (squar
in the presence of 10 mM H2DCFDA. The values are expressed as the percentage of the con
control level (P < 0.05).The anticancer activity of the structural related flavonoid
luteolin (high peroxyl scavenger capacity) in the A549 cell line at
24 h incubation is higher than that of apigenin (better hydroxyl
scavenger) but in both cases complexation did not improve the
cytotoxic behavior and the cellular ROS generation of the ligand
even though the in vitro antioxidant power changed upon
oxidovanadium(IV) complexation because of the different coordi-
nation modes with each flavonoid. It is important to be mentioned
that despite ROS production of both compounds on A549 cell line is
similar for the ligands and the complexes, in the case of apigenin
and VOapi, ROS and cytotoxic effects begin in parallel (at
concentrations higher than 80 mM at 24 h incubation). Therefore,
stress oxidative mechanisms could be assumed for the cell-killing
action in both cases.
On the other hand, the treatment with apigenin and VOapi in
HeLa cells caused a significant enhance in ROS accumulation in
mitochondria with a dose-dependent behavior (approximately
230% of the control level at 100 mM) as compared with untreated
control cells. Oxidovanadium(IV) cation generated a lower
increment of ROS levels (150% at 100 mM). The oxidative stress
increase induced by the compounds correlates quite well with the
inhibition of cell viability in both cancer cell lines producing
cancer-oxidative cell death.
Glutathione is the major nonenzymatic regulator of intracellu-
lar redox homeostasis, ubiquitously present in all cell types at
millimolar concentration. It exists in two forms, reduced (GSH) and
oxidized (GSSG) and participates in redox reactions by the
reversible oxidation of its active thiol. Within cells, total GSH
exists free and bound to proteins. Since the enzyme glutathione
reductase, which reverts free glutathione from its oxidized form is
constitutively active and inducible upon oxidative stress, free
glutathione is present almost exclusively in its reduced form [62].
In mammalian cells under physiological conditions, the GSH redox
couple is known to be present with steady-state concentrations of
1–10 mM. The overall ratio of GSH/GSSG in a cell is usually greater
than 100:1, and the redox couple GSH/GSSG is used as indicator of
changes in the redox environment and of oxidative stress in the
cell. In various models of oxidative stress, this ratio has been
demonstrated to decrease to values of 10:1 and even 1:1 [63]. As a
marker of cellular toxicity, the concentration of GSH was measuredConcentr ation ,  M
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Fig. 10. Effect of apigenin, VOapi and oxidovanadium(IV) cation on GSH cellular levels and GSH/GSSG ratio in A549 (A,B) and HeLa (C,D) cells. Results are expressed as
mean  SEM of three independent experiments, * significant differences in comparison with the control level (p < 0.05).
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compounds and the GSH/GSGG ratio was calculated because GSH
depletion by itself is not a major cause of cytotoxicity. From
(Fig. 10A) it can be seen that the GSH levels were reduced by ca.
13%, 17% and 52% relative to the untreated A549 cells in the
presence of 100 mM of apigenin, oxidovanadium(IV) cation and
VOapi, respectively (p < 0.05). The results obtained for apigenin are
in agreement with those previously reported [12,64].
On HeLa cells the compounds decreased ca. 50% the GSH levels
(Fig. 10C). As can be seen from Fig. 10B and D, apigenin,
oxidovanadium(IV) cation and VOapi induced a decrease in the
GSH/GSSG ratio in both cell lines. In the A549 cell line the effect of
the complex was more pronounced than that of the parent drugs,
though ROS production and cell viability were similar for the
ligand and the complex. The results indicate that the decrease of
the GSH/GSSG ratio was due not only to a decrease in the level of
GSH but also to an accumulation of GSSG.
The antioxidant enzymes as superoxide dismutase, catalase,
glutathione peroxidase, thioredoxin and glutaredoxin play impor-
tant roles in removing ROS and maintaining the redox state in cells.
In addition, many hydrophilic radical scavengers such as ascorbate
(vitamin C) and lipophilic radical scavengers like a-tocopherol
(vitamin E) protect cells from oxidative damage caused by ROS[65,66]. On the basis of the cellular generation of ROS and the
decrease of the cellular GSH/GSSG ratio produced by the
compounds, we assumed that the oxidative stress may play a
key role in their toxic effects. To confirm this hypothesis we studied
the effect of apigenin and VOapi on cell viability in the presence of
a mixture of vitamins C and E (Fig. 11) and the effect of NAC on the
level of ROS (Fig.12) generated by the compounds in the cultures of
both cell lines. It can be seen that when the cells were incubated in
the presence of natural antioxidants the treated-cell viability was
recovered. On the other hand, pretreatment of both cell lines with
5 mM of NAC and apigenin or VOapi suppressed the generation of
ROS in the A549 cell lines, and reduced the levels of ROS in treated-
HeLa cells with respect to the untreated cells. Then, it can be
demonstrated that oxidative stress is involved in the cell death
mechanism.
3.3.3. Morphological changes
A549 and HeLa cells exposed to 100 mM of VOapi for 24 h
showed morphological changes, evidenced by condensation of
cytoplasm and presence of pyknotic nuclei. VOapi at concentration
10 mM did not have an apparent effect compared to untreated
control in both cell lines (Fig. 13). These results agree with the
effects observed in the viability assay.
Fig. 12. Effect of N-acetyl-L-cysteine (NAC, 5 mM) on ROS production induced by apigenin (circles) and VOapi (triangles). The values are expressed as a percentage of the
control level and represent the mean  SEM. * significant values in comparison with the control level (P < 0.05).
Fig.11. Inhibitory effects of apigenin (circles) and VOapi (triangles) on A549 (A) and HeLa (B) cell viability in the presence of a mixture of vitamins C and E (each at 50 mM). The
cell line was treated with various concentrations of the compounds and a mixture of vitamins at 37 C for 24 h. The results are expressed as the percentage of the control level
and represent the mean  the standard error of the mean (SEM) from three separate experiments. All values are not different in comparison with the control level (P < 0.05).
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displayed a significantly inhibitory effect on the human lung and
human cervix cancer cell viability particularly at 48 h incubation
time. One of the possible mechanisms of action by which the
compounds induce cell death involved oxidative stress with an
increase in the cellular ROS levels that could cause GSH depletion
producing cellular redox imbalance.
3.4. Toxicological assays
3.4.1. Artemia salina tests
The Artemia salina L. test is useful for the screening of novel
drugs in order to predict their toxicity and has shown a good
correlation (r = 0.85 p < 0.05) with the assays in mice, suggesting
that the brine shrimp bioassay is a useful alternative model [67].
The mortality of brine shrimp for every concentration of VOCl2 was
previously reported [14], and it has been shown that it increased in
a dose-response manner with a LC50 value (dose required to kill
half of the members of the tested population, 244 mM). On theother hand, dead nauplii were not observed for the ligand apigenin
and the VOapi complex at the tested concentrations showing that
the flavonoid and the complex did not exert toxic effects at
concentrations up to 300 mg mL1.
3.4.2. Ames test
The Ames Salmonella typhimurium assay has been used to
identify substances that can produce genetic damage that leads to
gene mutations. The test uses Salmonella strains with preexisting
mutations that are not capable to synthesize histidine, and then are
not able to grow or form colonies in its absence. Compounds with
mutagenic potential may restore the genes function (reversion
assay). Consequently, a positive test indicates that the compound is
mutagenic and therefore may act as a carcinogen. A sample was
considered positive when the mutagenic index (MI) was equal or
greater than 2 for at least one of the tested doses and if it had a
reproducible dose-response curve [37]. It can be seen in Table 5
that the oxidovanadium(IV) cation, the ligand apigenin and the
VOapi complex did not exert mutagenic action on the tested
Fig. 13. Effect on cell morphology of the treatment of (a) A549 and (b) HeLa cell line with VOapi. Cells were incubated for 24 h without drug addition (control) and with VOapi
(10 and 100 mM, 40).
Table 5
Induction of His+ revertants (Rev) in Salmonella typhimurium TA98 and Salmonella typhimurium TA100 by the oxidovanadium(IV) cation, the ligand apigenin and the VOapi
complex without metabolic activation (S9 mix).
Compounds Concentration (mg/plate) S. typhimurium TA98 S. typhimurium TA100
Rev/platea MIb Rev/platea MIb
Strain control 34.5  0.5c – 139.5  1.5 –
VOCl2 75 26  3c 0.75c – –
37.5 30  2c 0.87c – –
18.8 30  2c 0.87c 97.5  2.5 0.70
Strain control 22.5  1.5 – 100.5  1.5 –
Apigenin 300 – – 69  2 0.69
150 23  2 1.02 80.5  1.5 0.80
75 24  1 1.07 96  2 0.95
37.5 17  1 0.75 91.5  1.5 0.91
18.75 20.5  1.5 0.91 76  2 0.76
VOapi 300 – – 64  1 0.64
150 13.5  1.5 0.60 59.5  1.5 0.59
75 18  2 0.80 74  1 0.74
37.5 14.5  1.5 0.64 68  2 0.68
18.8 18  1 0.80 73  1 0.73
a Number of revertants/plate: mean of two independent experiments  SD.
b MI: mutagenic index (number of His+ induced in the sample/number of spontaneous His+ in the negative control).
c Taken from ref [14].
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determined at concentrations higher than 75 mg/plate and
18.75 mg/plate due to the antimicrobial action exerted by VOCl2
against Salmonella typhimurium TA98 and Salmonella typhimurium
TA100, respectively. The ligand apigenin and the VOapi complex
showed antimicrobial activity against Salmonella typhimurium
TA98 at concentrations higher than150 mg/plate. The absence of
mutagenic activity of VOCl2 in the Ames test employing Salmonella
typhimurium TA98 was previously reported [14]. The mutagenic
index value resulted lower than 2 in all the cases showed that the
tested substances could not induce an increase in the number of
revertants. These results indicated that the tested compounds did
not induce frameshift mutations (S. typhimurium TA98) or base-
pair substitution mutations (S. typhimurium TA100) at the tested
concentrations.
3.5. Bovine serum albumin (BSA) interaction
3.5.1. Fluorescence quenching studies
The interaction between biomacromolecules, especially those
between plasma proteins and drugs, has been an interesting
research field in life sciences, chemistry, and clinical medicine.
Bovine serum albumin (BSA) is used as the model protein for drug
delivery because of its medical importance, abundance, low cost,
ease of purification, unusual ligand-binding properties and that it
is widely accepted in the pharmaceutical industry. The studies
concerning the interaction and potential transport with bovine
serum albumin were performed with apigenin and VOapi
measuring the fluorescence intensity of the BSA before and after
the addition of these compounds. The interaction with oxidovana-
dium(IV) cation was previously discussed [38]. A strong fluores-
cence emission of BSA assigned to the two tryptophan residues of
the protein (located at positions 134 and 212, respectively) that
possess intrinsic fluorescence has been displayed (Fig. 14) [68]. The
effects of apigenin and VOapi complex on the intrinsic BSA
fluorescence are shown in Fig. 14. For both compounds the
fluorescence intensities of BSA decreased with the increase of the
concentration, accompanied by a slight blue-shift of the maximum
emission wavelengths in the fluorescence spectra suggesting that
the binding is possibly associated with changes in the dielectric
environment of at least one of the two indole rings in BSA [69].
To confirm the quenching mechanism the fluorescence data at
different temperatures have been analyzed with the Stern-Volmer
Eq. (1) [70]:
F0/F = 1 + Kqt0[Q] = 1 + KSV[Q] (1)Fig. 14. The fluorescence spectra of BSA at various concentrations of where F0 and F are the fluorescence intensities in the absence and
presence of quencher, respectively; Kq is the bimolecular quench-
ing constant; t0 is the lifetime of the fluorophore in the absence of
quencher; [Q] is the concentration of quencher and Ksv is the Stern-
Volmer quenching constant which can be obtained from the slope
of eq. (1). Fig. 15 displays the Stern-Volmer plots of the quenching
of BSA fluorescence by apigenin (Fig. 15A) and VOapi (Fig. 15B) at
different temperatures. It can be observed that the plots largely
deviated from linearity toward the y-axis at concentrations higher
than 10 mM. The upward curvature indicated that the quenching
type is a combined quenching (both static and dynamic) [70] but at
lower concentrations a single quenching (static or dynamic)
probably takes place. The Stern-Volmer plots were used to
elucidate these assumptions at lower concentrations, and a linear
correlation has been obtained for both compounds (insets, Fig. 15C
and D, respectively). In Table 6 the calculated values of Ksv are
presented showing a decrease with temperature. When the
bimolecular quenching constants Kq are calculated using the
well-known relationship (Kq = Ksv/t0, t0 = 108 s, Table 6), values
much greater than the maximum dynamic quenching constant
2.0  1010M1 s1 have been obtained. These results suggested that
the interaction between the compounds and BSA most probably
occurred by static quenching [70].
3.5.2. Binding constants and the number of binding sites
The determination of the level of compound binding with
serum albumin is critical and will directly correlate with the
transport, disposition, and in vivo efficacy of the compound. The
value of the binding constant, Ka, is essential to understand the
distribution of compounds in plasma since a weak binding can
result in comparatively high concentrations of the drug in the
plasma, resulting in a shorter life time while a strong binding can
decrease the concentrations of compound in plasma, improving
the pharmacological effect. On the assumption that the fluores-
cence quenching of protein could be a static quenching process
(complex formation between protein and quencher), the equilib-
rium between free and bound molecule could be given by the
following Eq. (2):
log [(F0-F)/F] = log Ka + n log [Q] (2)
where n is the number of binding sites. The Ka and n values at
different temperatures acquired from the plots shown in Fig. 16 are
listed in Table 6. It was found that the binding constant decreased
with an increase in temperature, resulting in a reduction of the
stability of the compound-BSA system. Comparing the binding
constants of apigenin-BSA and VOapi-BSA systems, it was foundapigenin (A) and VOapi (B). lex = 280 nm, [BSA] = 6 mM, T = 298 K.
Fig.15. Plots of F0/F vs [Q] for BSA with apigenin (A) and VOapi (B) at different temperatures ((*), 298 K; (!), 303 K; (&), 310 K), lex = 280 nm. Inset: F0/F vs [Q] of apigenin (C)
and VOapi (D) at concentrations of 2.5 106, 5 106, 7.5 106 and 1 105M.
Table 6
Stern-Volmer constant (Ksv), quenching rate constant (Kq), binding constant (Ka) and n binding sites for the interaction of apigenin and VOapi with BSA (6 mM) in Tris-HCl
buffer (0.1 M, pH 7.4).
Compounds T (K) Ksv (x 104) (M1) r2 Kq (x 1012) (M1s1) Ka (x 105) (M1) n
apigenin 298 10.71  0.10 0.98 10.71  0.10 5.22  0.24 1.15  0.01
303 9.77  0.19 0.99 9.77  0.19 2.50  0.06 1.09  0.01
310 8.43  0.11 0.99 8.43  0.11 0.75  0.33 0.99  0.04
VOapi 298 12.89  0.18 0.99 12.89  0.18 150.41  7.59 1.43  0.01
303 12.47  0.11 0.99 12.47  0.11 51.16  3.16 1.34  0.01
310 11.15  0.21 0.98 11.15  0.21 5.88  4.63 1.14  0.07
r2 is the correlation coefficient for the KSV values.
Fig. 16. Plots of log [(F0F)/F] vs. log [Q] for the apigenin-BSA system (A) and VOapi-BSA system (B): (*), 298 K; (!), 303 K; (&), 310 K, [BSA] = 6 mM, lex = 280.
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ligand. The number of binding sites of the compounds with BSA
(n = 0.99-1.43) was ca. 1.0 and corresponded to the binding sites
with high affinity. The obtained binding constants are in the
intermediate range so that they are not too low to prevent efficient
distribution and are not so high to lead to decreased plasma
concentration. These data suggested that apigenin and VOapi can
be stored and removed by BSA. Our results for Ksv, Ka, n and the
thermodynamic parameters (negative values of DH and DS, see
below) agree with previous data reported for apigenin [71]. On the
other hand, it is important to mention that there are somediscrepancies in the literature for the interaction of apigenin with
bovine serum albumin being the Ksv, Ka or the thermodynamic
parameters quite different from each other [72–74]. These
differences have been attributed to the different experimental
conditions used in each determination [74] (differences in albumin
and flavonoid concentrations, albumin fractions and/or dissolution
media: pH values and the concentrations of NaCl and Mg2+).
3.5.3. Thermodynamic parameters
The interaction forces between drugs and biomolecules may
include electrostatic interactions, multiple hydrogen bonds, van
98 J.J. Martínez Medina et al. / Journal of Photochemistry and Photobiology A: Chemistry 344 (2017) 84–100der Waals interactions, hydrophobic and steric contacts within the
antibody-binding site, etc [75]. To infer the type of process of the
interaction between apigenin and VOapi with BSA, thermody-
namic parameters, including enthalpy change (DH), entropy
change (DS) and free energy change (DG) were investigated. If
DH does not vary significantly over the temperature range studied,
then its value and that of DS can be evaluated from the van’t Hoff
Eq. (3):
ln Ka =DH/RT+ DS/R (3)
where Ka is analogous to the associative binding constants at the
corresponding temperature and R is the gas constant. The free
energy change (DG) is then estimated from the following
relationship (4):
DG = DH  TDS (4)
The negative sign obtained for DG (Table 7) indicated a
spontaneous interaction process. The negative enthalpy change
suggested that the binding between the compounds and BSA was
exothermic and then the association constant decrease with
increasing temperature [75].
An important source of a negative contribution to DH and DS
will arise if a hydrogen bond is formed and furthermore the
interactions involving delocalized electrons of aromatic ring
systems make significant contributions to their negative sign.
The negative DH and DS values obtained for the interaction of
apigenin and VOapi with BSA indicated that the binding is mainly
enthalpy driven with an unfavorable entropic factor and therefore
the hydrogen bonding and van der Waals forces played major roles
during the interactions [75].
An interaction between BSA and metal complexes often leads to
a perturbation of the secondary structure of the protein, by
disrupting the disulfide bonds and leading to a partial loss of
a-helix conformation with the subsequent unfolding of the
protein, or a change in the polarity of the environment to which
the tryptophan residues are exposed, as a result of molecular
interactions, such as excited-state reactions, molecular rearrange-
ments, energy transfer, ground-state complex formation or
collision quenching [76]. For the VOapi complex, a BSA-complex
formation interaction has been determined. A similar interaction
has been assumed for the oxidovanadium(IV) complexes of
luteolin [51] and baicalin [14] with an interaction that favors
BSA complex formation and binding constant values of similar
magnitude order (79.4 106M1 and 13.5 106M1, respectively).
Furthermore, it has been determined that the reversible binding
occurs through one of the high affinity sites of the albumin (n = 1.5–
1.3) [77]. for all the measured VOflavonoid complexes.
4. Conclusions
A new oxidovanadium(IV) metal complex with the flavonoid
apigenin has been synthesized and characterized by elemental
analysis, spectroscopic techniques, thermal and computational
studies. In vitro cytotoxicity testing showed that the compounds
exhibit significant cytotoxicity towards tumor cell lines, especiallyTable 7
Thermodynamic parameters for the interactions between apigenin and VOapi with
BSA.
Compounds DH (KJ/mol) DS (J/mol) DG (KJ/mol)
apigenin 124.62 308.46 -32.70 (298 K)
-31.16 (303 K)
-29.00 (310 K)
VOapi 209.35 564.15 -41.23 (298 K)
-38.41 (303 K)
-34.46 (310 K)for the HeLa cell line, they did not exert toxic effects against
Artemia salina and did not behave as mutagenic agents indicating
that these compounds have the potential to act as effective metal-
based anticancer drugs. According to the structural features of
apigenin it exerted mild antioxidant activities. However, in
cultured cells the levels of ROS are increased and GSH and GSH/
GSSG depletion could be observed in parallel with the decreased
cell viability (more effective in the HeLa cell line), suggesting a
stress oxidative mechanism of cell-killing. Moreover, the com-
pounds could be stored and transported by bovine serum albumin
interacting by complex formation between protein and quencher
through hydrogen bonding and van der Waals forces. A similar
interaction has previously been determined for other VOflavonoid
complexes and the binding constants of these complexes displayed
the same order of magnitude.
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